BeiGene pays $270m for PD-1 antibody boosting drug
BeiGene partners with BioAtla to develop and commercialise the latter’s CTLA-4 antibody, which will be explored for use alongside a PD-1 antibody.
Archives for April 10, 2019
Bluebird ramps up lentiviral vector production with Durham Facility
Bluebird bio opens its first wholly owned manufacturing facility to produce lentiviral vectors for the company’s investigational gene and cell therapies.